Protein interactions and misfolding analyzed by AFM force spectroscopy

Journal of Molecular Biology

Volumn 354, Issue 5, 2005, Pages 1028-1042

  McAllister, Chad ^a   Karymov, Mikhail A ^a,b   Kawano, Yoshiko ^a   Lushnikov, Alexander Y ^a,b   Mikheikin, Andrew ^b   Uversky, Vladimir N ^c,d   Lyubchenko, Yuri L ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

AFM; Amyloids; Force spectroscopy; Intermolecular interaction; Protein misfolding

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; LYSOZYME;

ARTICLE; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION; SPECTROSCOPY;

EID: 28144446420     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.10.012     Document Type: Article

References (71)

1. J.W. Kelly The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways Curr. Opin. Struct. Biol. 8 1998 101 106
2. C.M. Dobson Protein misfolding, evolution and disease Trends Biochem. Sci. 24 1999 329 332
3. V. Bellotti, P. Mangione, and M. Stoppini Biological activity and pathological implications of misfolded proteins Cell Mol. Life Sci. 55 1999 977 991
4. V.N. Uversky, A. Talapatra, J.R. Gillespie, and A.L. Fink Protein deposits as the molecular basis of amyloidosis. I. Systemic amyloidoses Med. Sci. Monitor 5 1999 1001 1012
5. V.N. Uversky, A. Talapatra, J.R. Gillespie, and A.L. Fink Protein deposits as the molecular basis of amyloidosis. II. Localized amyloidosis and neurodegenerative disorders Med. Sci. Monitor 5 1999 1238 1254
6. J.C. Rochet, and P.T. Lansbury Jr Amyloid fibrillogenesis: themes and variations Curr. Opin. Struct. Biol. 10 2000 60 68
7. V.N. Uversky, and A.L. Fink Conformational constraints for the amyloid fibrillation: the importance of being unfolded Biochim. Biophys. Acta 1698 2004 131 153
8. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890
9. C.M. Dobson Principles of protein folding, misfolding and aggregation Semin. Cell Dev. Biol. 15 2004 3 16
10. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, and J. Zurdo Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
11. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
12. W.B. Stine Jr, K.N. Dahlgren, G.A. Krafft, and M.J. LaDu In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis J. Biol. Chem. 278 2003 11612 11622
13. A.T. Petkova, Y. Ishii, J.J. Balbach, O.N. Antzutkin, R.D. Leapman, F. Delaglio, and R. Tycko A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl Acad. Sci. USA 99 2002 16742 16747
14. R. Tycko Insights into the amyloid folding problem from solid-state NMR Biochemistry 42 2003 3151 3159
15. R. Tycko, and Y. Ishii Constraints on supramolecular structure in amyloid fibrils from two-dimensional solid-state NMR spectroscopy with uniform isotopic labeling J. Am. Chem. Soc. 125 2003 6606 6607
16. V.N. Uversky, J. Li, P. Souillac, I.S. Millett, S. Doniach, and R. Jakes Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins J. Biol. Chem. 277 2002 11970 11978
17. V.N. Uversky A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders J. Biomol. Struct. Dynam. 21 2003 211 234
18. J.Q. Trojanowski Rotenone neurotoxicity: a new window on environmental causes of Parkinson's disease and related brain amyloidoses Expt. Neurol. 179 2003 6 8
19. J.Q. Trojanowski, and V.M. Lee Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses Ann. NY Acad. Sci. 991 2003 107 110
20. D. Lundvig, E. Lindersson, and P.H. Jensen Pathogenic effects of alpha-synuclein aggregation Brain Res. Mol. Brain Res. 134 2005 3 17
21. M.C. Bennett The role of alpha-synuclein in neurodegenerative diseases Pharmacol. Ther. 105 2005 311 331
22. D.L. Pountney, N.H. Voelcker, and W.P. Gai Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis Neurotox. Res. 7 2005 59 67
23. M.J. Volles, and P.T. Lansbury Jr Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease Biochemistry 42 2003 7871 7878
24. M.M. Dedmon, J. Christodoulou, M.R. Wilson, and C.M. Dobson Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species J. Biol. Chem. 280 2005 14733 14740
25. I.V. Murray, B.I. Giasson, S.M. Quinn, V. Koppaka, P.H. Axelsen, and H. Ischiropoulos Role of alpha-synuclein carboxy-terminus on fibril formation in vitro Biochemistry 42 2003 8530 8540
26. J.C. Kessler, J.C. Rochet, and P.T. Lansbury Jr N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation Biochemistry 42 2003 672 678
27. W. Hoyer, T. Antony, D. Cherny, G. Heim, T.M. Jovin, and V. Subramaniam Dependence of alpha-synuclein aggregate morphology on solution conditions J. Mol. Biol. 322 2002 383 393
28. K.A. Conway, J.C. Rochet, R.M. Bieganski, and P.T. Lansbury Jr Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349
29. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, J.D. Harper, R.E. Williamson, and P.T. Lansbury Jr Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants Ann. NY Acad. Sci. 920 2000 42 45
30. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl Acad. Sci. USA 97 2000 571 576
31. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron, and A.L. Biere alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease J. Biol. Chem. 274 1999 19509 19512
32. V.N. Uversky, J. Li, and A.L. Fink Evidence for a partially folded intermediate in alpha-synuclein fibril formation J. Biol. Chem. 276 2001 10737 10744
33. M.B. Pepys, P.N. Hawkins, D.R. Booth, D.M. Vigushin, G.A. Tennent, and A.K. Soutar Human lysozyme gene mutations cause hereditary systemic amyloidosis Nature 362 1993 553 557
34. L.A. Morozova-Roche, J. Zurdo, A. Spencer, W. Noppe, V. Receveur, and D.B. Archer Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants J. Struct. Biol. 130 2000 339 351
35. M. Malisauskas, J. Ostman, A. Darinskas, V. Zamotin, E. Liutkevicius, E. Lundgren, and L.A. Morozova-Roche Cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro: does it imply innate amyloid toxicity? J. Biol. Chem. 280 2005 6269 6275
36. L. Arnaudov, and R. de Vries Thermally induced fibrilar aggregation of hen egg white lysozyme Biophys. J. 2005 ?????
37. J. Goers, S.E. Permyakov, E.A. Permyakov, V.N. Uversky, and A.L. Fink Conformational prerequisites for alpha-lactalbumin fibrillation Biochemistry 41 2002 12546 12551
38. Y.F. Dufrene Recent progress in the application of atomic force microscopy imaging and force spectroscopy to microbiology Curr. Opin. Microbiol. 6 2003 317 323
39. A.P. Limansky, L.S. Shlyakhtenko, S. Schaus, E. Henderson, and Y.L. Lyubchenko Aminomodified probes for atomic force microscopy Probe Microsc. 2 2002 227 234
40. C.K. Riener, C.M. Stroh, A. Ebner, A.A. Gall, C. Klampfl, and C. Romanin A simple test system for single molecule recognition force microscopy Anal. Chim. Acta 479 2003 59 75
41. Q. Zhang, E.T. Powers, J. Nieva, M.E. Huff, M.A. Dendle, and J. Bieschke Metabolite-initiated protein misfolding may trigger Alzheimer's disease Proc. Natl Acad. Sci. USA 101 2004 4752 4757
42. Y.L. Lyubchenko, and L.S. Shlyakhtenko Visualization of supercoiled DNA with atomic force microscopy in situ Proc. Natl Acad. Sci. USA 94 1997 496 501
43. L.S. Shlyakhtenko, A.A. Gall, J.J. Weimer, D.D. Hawn, and Y.L. Lyubchenko Atomic force microscopy imaging of DNA covalently immobilized on a functionalized mica substrate Biophys. J. 77 1999 568 576
44. M.D. Shtilerman, T.T. Ding, and P.T. Lansbury Jr Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41 2002 3855 3860
45. L.C. Serpell Alzheimer's amyloid fibrils: structure and assembly Biochim. Biophys. Acta 1502 2000 16 30
46. J.L. Jimenez, E.J. Nettleton, M. Bouchard, C.V. Robinson, C.M. Dobson, and H.R. Saibil The protofilament structure of insulin amyloid fibrils Proc. Natl Acad. Sci. USA 99 2002 9196 9201
47. D. Canet, A.M. Last, P. Tito, M. Sunde, A. Spencer, and D.B. Archer Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme Nature Struct. Biol. 9 2002 308 315
48. F.G. De Felice, M.N. Vieira, M.N. Meirelles, L.A. Morozova-Roche, C.M. Dobson, and S.T. Ferreira Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure FASEB J. 18 2004 1099 1101
49. E. Frare, P. Polverino De Laureto, J. Zurdo, C.M. Dobson, and A. Fontana A highly amyloidogenic region of hen lysozyme J. Mol. Biol. 340 2004 1153 1165
50. K.R. Babu, and V. Bhakuni Ionic-strength-dependent transition of hen egg-white lysozyme at low pH to a compact state and its aggregation on thermal denaturation Eur. J. Biochem. 245 1997 781 789
51. D.V. Vezenov, A. Noy, L.F. Rozsnyai, and C.M. Lieber Force titrations and ionization state sensitive imaging of functional groups in aqueous solutions by chemical force microscopy J. Am. Chem. Soc. 119 1997 2006 2015
52. I.V. Razlutskii, L.S. Shlyakhtenko, and Y.L. Lyubchenko The DNA melting profile is sensitive to point mutations (in Russian) Biopolimery Kletka 4 1988 357 361
53. R. Khurana, C. Ionescu-Zanetti, M. Pope, J. Li, L. Nielson, and M. Ramirez-Alvarado A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy Biophys. J. 85 2003 1135 1144
54. V.N. Uversky, J. Li, and A.L. Fink Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease FEBS Letters 500 2001 105 108
55. A.B. Manning-Bog, A.L. McCormack, J. Li, V.N. Uversky, A.L. Fink, and D.A. Di Monte The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein J. Biol. Chem. 277 2002 1641 1644
56. V.N. Uversky, J. Li, K. Bower, and A.L. Fink Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease Neurotoxicology 23 2002 527 536
57. V.N. Uversky, J. Li, and A.L. Fink Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284 44296
58. V.N. Uversky, J. Li, and A.L. Fink Trimethylamine-N-oxide-induced folding of alpha-synuclein FEBS Letters 509 2001 31 35
59. L.A. Munishkina, C. Phelan, V.N. Uversky, and A.L. Fink Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes Biochemistry 42 2003 2720 2730
60. V.N. Uversky, G. Yamin, P.O. Souillac, J. Goers, C.B. Glaser, and A.L. Fink Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS Letters 517 2002 239 244
61. G. Yamin, C.B. Glaser, V.N. Uversky, and A.L. Fink Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein J. Biol. Chem. 278 2003 27630 27635
62. H. Wang, R. Bash, J.G. Yodh, G.L. Hager, D. Lohr, and S.M. Lindsay Glutaraldehyde modified mica: a new surface for atomic force microscopy of chromatin Biophys. J. 83 2002 3619 3625
63. P.L. Privalov, and N.N. Khechinashvili A thermodynamic approach to the problem of stabilization of globular protein structure: a calorimetric study J. Mol. Biol. 86 1974 665 684
64. M. Fandrich, M.A. Fletcher, and C.M. Dobson Amyloid fibrils from muscle myoglobin Nature 410 2001 165 166
65. T.A. Pertinhez, M. Bouchard, E.J. Tomlinson, R. Wain, S.J. Ferguson, C.M. Dobson, and L.J. Smith Amyloid fibril formation by a helical cytochrome FEBS Letters 495 2001 184 186
66. C.M. Dobson Protein folding and its links with human disease Biochem. Soc. Symp. 2001 1 26
67. V.N. Uversky, and A.L. Fink Conformational constraints for amyloid fibrillation: the importance of being unfolded Biochim. Biophys. Acta 1698 2004 131 153
68. L.S. Shlyakhtenko, A.A. Gall, J.J. Weimer, D.D. Hawn, and Y.L. Lyubchenko Atomic force microscopy imaging of DNA covalently immobilized on a functionalized mica substrate Biophys. J. 77 1999 568 576
69. L.S. Shlyakhtenko, A.A. Gall, A. Filonov, Z. Cerovac, A. Lushnikov, and Y.L. Lyubchenko Silatrane-based surface chemistry for immobilization of DNA, protein-DNA complexes and other biological materials Ultramicroscopy 97 2003 279 287
70. D.A. Walters, J.P. Cleveland, N.H. Thomson, and P.K. Hansma Short cantilevers for atomic force microscopy Rev. Sci. Instrum. 67 1996 3583 3590
71. T.H. Huang, D.S.. Yang, N.P. Plaskos, S. Go, C.M. Yip, P.E. Fraser, and L.A. Chakrabartty Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide J. Mol. Biol. 297 2000 73 87